Mesa Laboratories Inc. /CO/ (MLAB) intrinsic value & 10-year financials

Mesa Laboratories Inc. /CO/ (MLAB) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 11.5% a year to $249.1M, with an average return on invested capital of -6.9%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$122.48
Market cap
$681.6M
Revenue (FY2026)
$249.1M
Revenue growth (10-yr CAGR)
11.5%
ROIC (10-yr avg)
-6.9%
Free cash flow (FY2026)
$39.6M

MLAB 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2026 $249.1M $6.7M $1.21 $39.6M 7.4% 4.5%
FY2025 $241.0M -$2.0M -$0.36 $42.6M 6.8% 4.8%
FY2024 $216.2M -$254.2M -$47.20 $41.6M -125.9% -102.4%
FY2023 $219.1M $930.0K $0.17 $23.4M 1.5% 0.5%
FY2022 $184.3M $1.9M $0.35 $34.8M 2.6% 0.6%
FY2021 $133.9M $3.3M $0.64 $35.1M 9.2% 3.9%
FY2020 $117.7M $1.3M $0.31 $25.1M 6.4% 3.0%
FY2019 $103.1M $7.5M $1.86 $29.3M 9.5% 6.4%
FY2018 $96.2M -$3.0M -$0.79 $22.0M 2.3% 0.8%
FY2017 $93.7M $11.2M $2.91 — 17.4% 8.7%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

MESA LABORATORIES INC /CO/ is a consistent compounder, expanding top-line revenue at 11.5% annually over the past decade.

MESA LABORATORIES INC /CO/ has historically struggled to out-earn its cost of capital, averaging just -6.9% ROIC.

MESA LABORATORIES INC /CO/ has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, MESA LABORATORIES INC /CO/ is modeled at -9.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-10.52 per share.

MLAB stock: frequently asked questions

What is the intrinsic value of Mesa Laboratories Inc. /CO/ (MLAB) stock?

Graham's formula only works with positive earnings. Mesa Laboratories Inc. /CO/ reported diluted EPS of $1.21 in fiscal 2026, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Mesa Laboratories Inc. /CO/ grown?

Revenue went from $93.7M in fiscal 2017 to $249.1M in fiscal 2026, a compound annual growth rate of 11.5%. Net income was $6.7M in fiscal 2026.

Does Mesa Laboratories Inc. /CO/ generate free cash flow?

Mesa Laboratories Inc. /CO/ generated $39.6M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2026. Free cash flow was positive in 9 of the last 9 reported years.

What is MLAB's return on invested capital?

Average ROIC over the last 10 fiscal years was -6.9%, and average return on equity was -7.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this MLAB data come from?

From Mesa Laboratories Inc. /CO/'s annual 10-K filings on SEC EDGAR, most recently filed Jun 3, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar industrial instruments for measurement, display, and control stocks